Dr. Lyden is Professor of Physiology & Neuroscience and Neurology at the Zilkha Neurogenetic Institute in the Keck School of Medicine at USC. Dr. Lyden helped lead the pivotal NINDS t-PA for Acute Stroke Trial. Dr. Lyden is the Principal investigator of the NINDS-sponsored Stroke Preclinical Assessment Network, or SPAN, and Principal Investigator of the pivotal trial RHAPSODY-2. He is the Immediate Past Chair of the Stroke Council of the American Stroke Association and is a Fellow of the American Academy of Neurology, American Neurology Association, American Heart Association. He was awarded the William M. Feinberg Award for Excellence in Clinical Stroke by the ASA. Dr. Lyden’s laboratory works on finding new treatments for stroke, and understanding cerebral pathobiology during stroke.